| BioWorld

Stock Winners and Losers For The Week

Clinical Trials Update: October 2004

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2004

FDA Submissions, Approvals And Other Actions: October 2004

BioWorld Stock Report For Public Biotechnology Companies

Medarex's Landmark Deal With BMS: 'What We Set Out To Do'

Industry leaders like to use phrases such as "going forward" and "as the company evolves," even though a troubling number of firms in biotechnology (and other industries) tend instead to stall, slide or die. Read More

Money Raised Year To Date

BioWorld

Nov. 15, 2004

Stock Winners and Losers For The Week

Clinical Trials Update: October 2004

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2004

FDA Submissions, Approvals And Other Actions: October 2004

BioWorld Stock Report For Public Biotechnology Companies

Medarex's Landmark Deal With BMS: 'What We Set Out To Do'

Money Raised Year To Date

Today's news in brief

Today's news in brief

Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA

News in brief

23andme founder-led group outbids Regeneron for company